ARCH Venture Partners
VC
1986
$9 000 M
Chicago, Illinois, United States
Profile
ARCH Venture Partners is a venture capital firm based in Chicago, Illinois, founded in 1986. The firm is known for its focus on life sciences and deep-science platforms, often co-founding companies with leading scientists and entrepreneurs. ARCH has a team of 47 professionals, including 11 partners, and is recognized for its deep involvement in the commercialization of technologies developed at academic research institutions.
ARCH invests primarily in the life sciences sector, with a focus on biotechnology, health, AI, and medtech. The firm typically invests in Seed and Series A stages, with check sizes ranging from $500K to $5M. ARCH has raised multiple venture funds, including ARCH Venture Fund X and XI, with a total AUM exceeding $3 billion. The firm primarily invests in the United States but has a global reach through its extensive network.
Notable investments by ARCH Venture Partners include Illumina - genomics, Alnylam - RNAi therapeutics, Juno Therapeutics - cancer immunotherapy, Agios Pharmaceuticals - cellular metabolism, and Denali Therapeutics - neurodegenerative diseases. These companies highlight ARCH's commitment to advancing groundbreaking scientific discoveries.
Industry
ARCH Venture Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
ARCH Venture Fund X
|
Venture Capital (VC)
|
Healthcare Services
Media and Entertainment
SaaS
Software
Energy
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$1500 M
|
April 2020
|
|
Arch Venture Fund XI
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
Media and Entertainment
SaaS
Software
Energy
CleanTech
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$1900 M
|
January 2021
|
|
ARCH Venture Fund XIII, L.P.
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
Energy
CleanTech
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$3000 M
|
September 2024
|
